BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

656 related articles for article (PubMed ID: 17630119)

  • 21. Ligand-based gene expression profiling reveals novel roles of glucocorticoid receptor in cardiac metabolism.
    Yoshikawa N; Nagasaki M; Sano M; Tokudome S; Ueno K; Shimizu N; Imoto S; Miyano S; Suematsu M; Fukuda K; Morimoto C; Tanaka H
    Am J Physiol Endocrinol Metab; 2009 Jun; 296(6):E1363-73. PubMed ID: 19293335
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Pharmacology of glucocorticoids: beyond receptors.
    van der Laan S; Meijer OC
    Eur J Pharmacol; 2008 May; 585(2-3):483-91. PubMed ID: 18410913
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Molecular mechanisms of glucocorticoid receptor signaling.
    Labeur M; Holsboer F
    Medicina (B Aires); 2010; 70(5):457-62. PubMed ID: 20920967
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Novel therapeutic agents targeting the glucocorticoid receptor for inflammation and cancer.
    Sommer P; Ray DW
    Curr Opin Investig Drugs; 2008 Oct; 9(10):1070-7. PubMed ID: 18821468
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The role of calpains in ligand-induced degradation of the glucocorticoid receptor.
    Kim YS; Kim J; Kim Y; Lee YH; Kim JH; Lee SJ; Shin SY; Ko J
    Biochem Biophys Res Commun; 2008 Sep; 374(2):373-7. PubMed ID: 18640094
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Structure and function of the glucocorticoid receptor ligand binding domain.
    Bledsoe RK; Stewart EL; Pearce KH
    Vitam Horm; 2004; 68():49-91. PubMed ID: 15193451
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Glucocorticoid therapy-induced skin atrophy.
    Schoepe S; Schäcke H; May E; Asadullah K
    Exp Dermatol; 2006 Jun; 15(6):406-20. PubMed ID: 16689857
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Glucocorticoids: mechanisms of action and anti-inflammatory potential in asthma.
    van der Velden VH
    Mediators Inflamm; 1998; 7(4):229-37. PubMed ID: 9792333
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The molecular complexity of glucocorticoid actions in inflammation - a four-ring circus.
    Goulding NJ
    Curr Opin Pharmacol; 2004 Dec; 4(6):629-36. PubMed ID: 15525555
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Structure guided design of 5-arylindazole glucocorticoid receptor agonists and antagonists.
    Yates CM; Brown PJ; Stewart EL; Patten C; Austin RJ; Holt JA; Maglich JM; Angell DC; Sasse RZ; Taylor SJ; Uings IJ; Trump RP
    J Med Chem; 2010 Jun; 53(11):4531-44. PubMed ID: 20469868
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Optical probes to identify the glucocorticoid receptor ligands in living cells.
    Awais M; Sato M; Umezawa Y
    Steroids; 2007 Dec; 72(14):949-54. PubMed ID: 17897691
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The mechanisms of tumor suppressor effect of glucocorticoid receptor in skin.
    Chebotaev D; Yemelyanov A; Budunova I
    Mol Carcinog; 2007 Aug; 46(8):732-40. PubMed ID: 17538956
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Selective glucocorticoid receptor agonists for the treatment of inflammatory bowel disease: studies in mice with acute trinitrobenzene sulfonic acid colitis.
    Reuter KC; Grunwitz CR; Kaminski BM; Steinhilber D; Radeke HH; Stein J
    J Pharmacol Exp Ther; 2012 Apr; 341(1):68-80. PubMed ID: 22235147
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Receptor mechanisms of glucocorticoid and antiglucocorticoid effects].
    Golikov PP
    Vopr Med Khim; 1996; 42(3):184-92. PubMed ID: 9139449
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Agonist versus antagonist induce distinct thermodynamic modes of co-factor binding to the glucocorticoid receptor.
    Kroe RR; Baker MA; Brown MP; Farrow NA; Gautschi E; Hopkins JL; LaFrance RR; Kronkaitis A; Freeman D; Thomson D; Nabozny G; Grygon CA; Labadia ME
    Biophys Chem; 2007 Jul; 128(2-3):156-64. PubMed ID: 17466438
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Crosstalk between the glucocorticoid receptor and other transcription factors: molecular aspects.
    Kassel O; Herrlich P
    Mol Cell Endocrinol; 2007 Sep; 275(1-2):13-29. PubMed ID: 17689856
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Selective glucocorticoid receptor modulation: New directions with non-steroidal scaffolds.
    Sundahl N; Bridelance J; Libert C; De Bosscher K; Beck IM
    Pharmacol Ther; 2015 Aug; 152():28-41. PubMed ID: 25958032
    [TBL] [Abstract][Full Text] [Related]  

  • 38. New glucocorticoids on the horizon: repress, don't activate!
    Song IH; Gold R; Straub RH; Burmester GR; Buttgereit F
    J Rheumatol; 2005 Jul; 32(7):1199-1207. PubMed ID: 16041872
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The effects of non-genomic glucocorticoid mechanisms on bodily functions and the central neural system. A critical evaluation of findings.
    Haller J; Mikics E; Makara GB
    Front Neuroendocrinol; 2008 May; 29(2):273-91. PubMed ID: 18054070
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Identification of novel in vitro test systems for the determination of glucocorticoid receptor ligand-induced skin atrophy.
    Schoepe S; Schäcke H; Bernd A; Zöller N; Asadullah K
    Skin Pharmacol Physiol; 2010; 23(3):139-51. PubMed ID: 20051715
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 33.